SUNNYVALE, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER 2 study results have been published in the latest edition […]
Tag: ROADSTER-2
ROADSTER-2 Demonstrates Compelling Patient Outcomes with Strong Safety Profile
Final Results Presented in Late-Breaking Session at Society for Vascular Surgery 2019 Vascular Annual Meeting NATIONAL HARBOR, Maryland – June 15, 2019 – Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its […]